• 한국산업보건학회지
• /
• 제31권1호
• /
• pp.94-104
• /
• 2021

Objectives: A number of medical institutions have been conducting fit tests to perform seal checks on masks. This study aimed to compare the differences fit factor before and after domestic N95 mask-wearing training through a fit-test. Methods: A survey of 59 healthcare workers was conducted regarding whether they had undergone a fit test or received training on mask-wearing. Further, the fit of two types of domestic N95 masks was measured before and after the training using a QNFT(Quantitative Fit test). The average fit factors before and after training were compared using a paired t-test. Additionally the differences in the fit test pass rate were analyzed using a McNemar test. Results: A statistically significant difference was seen between the fit factors in the fit tests conducted before and after the training (p=0.0015), as well as in the fit of the two types of masks tested (p<0.01). Thus, an improvement in mask fitting was seen after the training, even with differently fitted masks. Conclusions: Upon using a QNFT, a significant increase in the fit factors for N95 masks was observed after training compared with masks that were fitted as usual. This highlights the importance of training in mask-wearing, with the conclusion that training healthcare providers will improve the fit of masks.

• 대한예방한의학회지
• /
• 제26권2호
• /
• pp.11-24
• /
• 2022

Objectives : This study was designed to investigate the effect of Banhahubak-tang on gastroesophageal reflux disease(GERD) through a systematic review and meta-analysis of randomized controlled trials(RCTs). Methods : RCTs using Banhahubak-tang on GERD was searched in databases such as EMBASE, PubMed, MEDLINE, CENTRAL, CNKI, KISS, RISS, ScienceON, and OASIS. RCTs published up to October 8th, 2021 were included. Meta-analysis was performed by synthesizing outcome data, including Total Effectiveness Rate (TER), Reflux Symptom Index(RSI), Reflux Finding Score(RFS), and Incidence of Adverse Reactions. RevMan 5.4 software was used for data analysis. The Cochrane collaboration bias risk assessment scale was used to evaluate the methodological quality of the included studies. Results : Ten RCTs met the inclusion criteria. The total effective rate was the most commonly used outcome measure. The meta-analysis revealed that the TER in the experimental group was higher than that of the control group(N=2, RR:1.22, 95% CI:1.09 to 1.36, P=0.0004, I²=0%)(N=6, RR:1.22, 95% CI:1.14 to 1.32, P<0.00001, I²=0%)(N=8, RR:1.22, 95% CI: 1.14 to 1.30, P<0.00001, I²=0%). On the other hand, RSI(N=2, MD : -4.29, 95% CI: -4.71 to -3.86, I²=94%), RFS(N=2, MD : -3.28, 95% CI: -3.71 to -2.85, I²=96%), and Incidence of Adverse Reactions(N=5, RR: 0.32, 95% CI: 0.17 to 0.61, I²=0%) in the experimental group were lower than that of the control group. Conclusion : Treatment with Banhahubak-tang was found to be effective on GERD. However the results might be biased because of the poor quality and small sample size of the included RCTs.

• Parasites, Hosts and Diseases
• /
• 제23권1호
• /
• pp.156-164
• /
• 1985

자유생활아에마중 병원성이 강한 것으로 알려진 Naegleria fowleri영양형 $5{\times}10^4$개를 생쥐의 비강내 로 감염시켜서 원발성 아메바성 뇌수막염을 받생시켰다. 그런 과정중 비장을 적출하여 그 영향에 대하여 생쥐의 체중과 수술후 회복기간별로 뇌수막염에 의한 사망율과 평균생존기간을 비교하였다. 또 생쥐의 혈청중 면역확산법으로 항체의 형성여부를 관찰하였으며, 각 실험군에서 채취한 혈청을 전기영동법을 실시하여 혈청단백질분획을 바교하였다. 본 실험결과 다음과 같은 성적을 얻었다. 1. 생후 3주째에 비장을 적출하고 1주일 후에 N. fowleri로 감염시킨 실험I에서 대조군, sham군, 비장적출군 사이의 사망율은 각각 100%, 85%, 95%이었으며, 평균생존기간은 7.3일, 7.5일, 7.8일이었다. 2. 생후 3주째에 비장을 적출하고 3주일 후에 N. fowleri를 감염시킨 실험 II에서 대조군, sham군, 비장적출군 사이의 사망율은 각각 95%, 95%, 95%이었으며, 평균생존기간은 12.1일, 11.5일, 11.5일이었다. 3. 생후 5주째에 비장을 적출하고 1주일 후에 N. fowleri를 감염시킨 실험 III에서 대조군, sham군, 비장적출군 사이의 사망율은 각각 95%, 90%, 95%이었으며, 평균생존기간은 8.1일, 8.3일, 8.6일 이었다. 4. 원발성 아에바성 뇌수막염이 발생된 생쥐의 혈청을 면역확산법을 실시한 결과, 항원-항체 복합체의 2중으로 된 침강대를 관찰하였다. 5. 혈청단백질분획의 비교는 다음과 같았다. 1) 비장을 적출한 후 N. fowleri를 감염 시키기 전에 채취한 혈청중, 대조군에서 분획 III, IV 이 sham군과 비장적출군에 비하여 다르게 나타났다. 2) 비장을 적출한 후 N. fowleri을 감염시켜서 뇌수막염을 발생시킨 생쥐의 혈청에서는 대조군과 sham군의 분획 II, III, V가 비장적출군과 달랐다. 3) 비장을 적출한 후 N. fowleri를 감염시키기 전에 채취한 혈청과 감염시킨 후 뇌수막염에 의하여 사망하기 직전에 채취한 혈청사이에서는 분획 I, III, N, V가 다르게 나타났다. 이상의 결과로 보아, 병원성이 강한 N. fowleri 영양형을 생쥐의 비강내로 떨어뜨려 원말성 아메바성 뇌수막염을 발생시킬 수 있었고, 비장을 적출하면 혈청 단백칠분획에는 차이를 나타낼지라도 생쥐의 사망율과 평균생존기간에는 아무런 영향을 주지 않았음을 알 수 있었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권12호
• /
• pp.7401-7407
• /
• 2013

Aim: To compare survival outcomes after whole brain radiation therapy (WBRT), stereotactic radiosurgery (SRS), and WBRT plus SRS combination therapy in Korea, by performing a quantitative systematic review. Materials and Methods: We searched 10 electronic databases for reports on Korean patients treated with WBRT or SRS for brain metastases published prior to July 2010. Independent reviewers screened all articles and extracted the data. When a Kaplan-Meier survival curve was available, median survival time and standard errors were calculated. Summary estimates for the outcomes in each study were calculated using the inverse variance random-effects method. Results: Among a total of 2,761 studies, 20 studies with Korean patients (n=1,053) were identified. A combination of 12 studies (n=566) with WBRT outcomes showed a median survival time of 6.0 months (95%CI: 5.9-6.2), an overall survival rate of 5.6% (95%CI: 1-24), and a 6-month survival rate of 46.5% (95%CI: 37.2-56.1). For nine studies (n=412) on SRS, the median survival was 7.9 months (95%CI: 5.1-10.8), and the 6-month survival rate was 63.1% (95%CI: 49.8-74.8). In six studies (n=75) using WBRT plus SRS, the median survival was 10.7 months (95%CI: 4.7-16.6), and the overall and 6-month survival rates were 16.8% (95%CI: 6.2-38.2) and 85.7% (95%CI: 28.3-96.9), respectively. Conclusions: WBRT plus SRS showed better 1-year survival outcome than of WBRT alone for Korean patients with metastatic brain tumors. However, the results of this analysis have to be interpreted cautiously, because the risk factors of patients were not adjusted in the included studies.

• 자원환경지질
• /
• 제40권2호
• /
• pp.191-207
• /
• 2007

경상분지 이외의 지역에 분포하는 백악기 암석에 대한 특성잔류자화 방향을 이해하기 위하여 한반도 남서부에 분포하는 부여분지와 함평분지의 백악기 암석에 대한 고지자기 연구를 수행하였다. 부여분지에 분포하는 퇴적암의 고지 자기 방향은 경사보정전의 방향$(D/I=356.5^{\circ}/61.5^{\circ},\;k=39.3\;\alpha_{95}=7.4^{\circ})$은 경사보정후의 방향$(D/I=25.0^{\circ}/60.6^{\circ},\;k=22.4,\;\alpha_{95}=9.9^{\circ})$보다 더 집중됨으로 습곡 이후 재자화된 것으로 볼 수 있으나, 경사보정후의 방향의 정밀도(k)와 신뢰도$(\alpha_{95})$ 경사보정 전의 값과 비교하여 신뢰할 수 있는 통계학적으로 여전히 양호한 값이며 경사보정 후의 극의 위치가 한반도 백악기의 극의 위치와 유사한 점 때문에 부여분지의 재자화 여부의 결정은 유보하였다. 경사보정 전의 고지자기극의 위치는 $(Lat./Long.=81.6^{\circ}N/106.9^{\circ}E,\;K=25.1\;A_{95}=9.3^{\circ})$는 유라시아 제3기의 고지자기 극과 유사하며, 경사보정 후의 고지자기극은 $(Lat./Long.=69.3^{\circ}N/186.7^{\circ}E,\;K=11.6\;A_{95}=14.0^{\circ})$로 한반도 후기 백악기의 극과 유사하다. 함평분지 퇴적암의 특성잔류자화 방향은 경사보정 후의 방향$D/I=32.5^{\circ}/55.4^{\circ},\;(k=35.6,\;\alpha_{95}=8.7^{\circ})$이 경사보정 전의 방향$D/I=18.3^{\circ}/62.5^{\circ},\;k=14.1,\;\alpha_{95}=14.2^{\circ})$보다 더 집중된다. 경사보정 후의 방향으로부터 계산된 고지자기극의 위치는 $Lat./Long.=63.9^{\circ}N/202.7^{\circ}E,\;(K=21.3,\;A_{95}=7.6^{\circ})$로 한반도 후기 백악기의 고지자기극$(Lat./Long.=70.9^{\circ}N/215.4^{\circ}E,\;A_{95}=5.3^{\circ})$의 위치와 유사하므로 암석의 생성 시기는 후기 백악기로 판단하였다. 한편 함평분지에 분포하는 백악기 화산암류에서는 한 개의 정자화 방향과 두 개의 역자화 방향이 확인되었다. 이들 특성잔류자화 방향은 백악기 화산암 형성 당시 암석에 기록된 성분으로써 당시 지구자기장의 상태를 기록한 것으로 해석하였으며, 이중 정자화 방향을 함평분지 화산암의 대표 방향으로 채택하였다 함평분지 화산암의 고지자기 극의 위치는 정자극의 경우는 $Lat./Long.=70.2^{\circ}N/199.5^{\circ}E,\;(K=18.1,\;A_{95}=9.6^{\circ})$ 이며 역자극의 경우는 $Lat./Long.=65.5^{\circ}S/251.3^{\circ}E,\;(K=7.1,\;A_{95}=20.7^{\circ})$이다. 이중 정자극의 위치는 한반도의 후기 백악기극의 위치와 통계적으로 동일한 것으로 나타나 함평분지 화산암의 형성 시기를 후기 백악기로 해석하였다.

• 대한한의학회지
• /
• 제41권3호
• /
• pp.205-220
• /
• 2020

Objectives: The aim of this review is to assess the clinical benefit of chuna for managing symptoms in chronic fatigue syndrome (CFS) Methods: We searched eligible studies from the following 11 databases with no language restriction: Pubmed, CENTRAL, Embase, CNKI, CQVIP, Wanfang, CiNii, OASIS, RISS and Koreamed. We selected randomized controlled trial (RCT), quasi-randomized controlled trial (Quasi-RCT) and controlled clinical trial (CCT) in which patients with chronic fatigue syndrome were treated with chuna. The results of the included studies were synthesized through meta-analysis, and their risk of bias were also assessed. Results: We searched 914 potentially relevant studies, and only 20 studies were selected for this systematic review. Meta-analysis showed that chuna was more effective in improving general symptoms (n=291, RR 0.19 [95% CI 0.11 to 0.32], Z=6.08, p<0.00001, I2=0%), fatigue (n=487, SMD -0.95 [95% CI -1.19 to -0.71], Z=7.76, p<0.00001, I2=37%) and sleep disorder (n=139, SMD -0.58 [95% CI -0.92 to -0.24], Z=3.36, p=0.0008, I2=0%) compared to health supplements or usual care. When chuna was used as an added intervention, it was more effective in improving general symptoms(n=729, RR 0.25 [95% CI 0.15 to 0.42], Z=5.19, p<0.00001, I2=0%) and fatigue severity alone(n=217, SMD -1.21 [95% CI -1.53 to -0.89], Z=7.45, p<0.00001, I2=15%) compared to control. Conclusion: We found that chuna was beneficial for improving severity of general symptoms and fatigue at post treatment in CFS patients.

• 한국재료학회:학술대회논문집
• /
• 한국재료학회 1997년도 한국재료학회 추계학술발표회
• /
• pp.95-95
• /
• 1997

• 한국생명과학회:학술대회논문집
• /
• 한국생명과학회 2003년도 제40회 국제학술심포지움
• /
• pp.95-95
• /
• 2003

• 한국재료학회:학술대회논문집
• /
• 한국재료학회 1998년도 IUMRS-ICEM ABSTRACT BOOK
• /
• pp.95.2-95
• /
• 1998

• 대한임상독성학회지
• /
• 제15권2호
• /
• pp.122-130
• /
• 2017

Purpose: To evaluate the effects of low-dose intravenous N-acetylcysteine on the prevention of contrast-induced nephropathy (CIN) in patients undergoing computed tomography (CT). Methods: All patients presenting to our emergency department and undergoing CT with intravenous contrast media between August 2014 and April 2016 were retrospectively enrolled. We included hospitalized patients with renal dysfunction [estimated glomerular filtration rate (GFR) between 30 and $89mL/min/1.73m^2$]. A 600-mg injection of N-acetylcysteine was given to patients once before and once immediately after CT, depending on the preference of physician. The primary outcome was CIN defined as an increase in creatinine level of ${\geq}25%$ or ${\geq}0.5mg/dL$ from the baseline within 48 to 72 hours after CT. A trained person blindly reviewed all medical records. Results: Of the 1903 admitted patients, CIN occurred in 9.8% of patients who received 1200 mg intravenous N-acetylcysteine (24/244) and 6.8% of patients who did not (113/1659, p=0.090). In a multivariable regression analysis, N-acetylcystine was not relevant to the prevention of CIN (odds ratio=1.42 [95% CI, 0.90-2.26]). Even in the stratified analysis using the propensity score matching, N-acetylcysteine was irrelevant (GFR 30-59: odds ratio=1.06 [95% CI, 0.43-2.60]; GFR 60-89: odds ratio=1.76 [95% CI, 0.75-4.14]). After adjustment, crystalloids were significantly associated with the reduction in CIN compared with dextrose water (odds ratio=0.60 [95% CI, 0.37-0.97]). Conclusion: No effect was found when low-dose intravenous N-acetylcysteine was used to prevent CIN. However, there seems to be an association between crystalloids and reduction in CIN.